Penumbra raises 2025 revenue guidance to $1.375B–$1.38B as CAVT and embolization drive growth

Q3 2025 Management View Adam Elsesser, Co-Founder, Chairman & CEO, opened by stating, "In the third quarter, we generated total revenue of $354.7 million, representing underlying year-over-year growth ...